Women's Cancer Care Associates, LLC

Summary

Women's Cancer Care Associates, LLC is a medical facility located in Albany, New York. This center is recognized for care of Ovarian Cancer, Fallopian Tube Cancer, Uterine Cancer, Peritoneal Cancer, Ovarian Carcinoma and other specialties. Women's Cancer Care Associates, LLC is involved with conducting 53 clinical trials across 63 conditions. There are 4 research doctors associated with this hospital, such as Emese Zsiros, JOYCE BARLIN, Shashikant B. Lele, and Peter Frederick, MD.

Top PIs

Clinical Trials running at Women's Cancer Care Associates, LLC

Ovarian Cancer

Endometrial Cancer

Uterine Cancer

Endometrial Adenocarcinoma

Uterine Carcinosarcoma

Fallopian Tube Cancer

Cancer

Peritoneal Neoplasm

Genital Diseases

Endometrioid Carcinoma

Mirvetuximab + Bevacizumab

for Ovarian Cancer

GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine + Bevacizumab as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.

Recruiting

2 awards

Phase 3

Mirvetuximab Soravtansine

for Ovarian Cancer

The purpose of this study is to evaluate the incidence rate and severity of prespecified mirvetuximab soravtansine (MIRV)-related ocular treatment-emergent adverse events (TEAEs) and assess prophylaxis strategies in all participants (symptomatic and asymptomatic) undergoing prospective ophthalmic evaluation with recurrent ovarian cancer (participants with either platinum-sensitive ovarian cancer \[PSOC\] or platinum-resistant ovarian cancer \[PROC\]) with high folate receptor alpha (FRα) expression.

Recruiting

1 award

Phase 2

Surgical Procedures

for Reducing Ovarian Cancer Risk

This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the fallopian tubes and ovaries. This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.

Recruiting

1 award

N/A